A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of KTN3379 in Adult Subjects With Advanced Tumors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02014909 |
|
Recruitment Status :
Completed
First Posted : December 18, 2013
Last Update Posted : July 24, 2017
|
Sponsor:
Celldex Therapeutics
Information provided by (Responsible Party):
Celldex Therapeutics
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | May 25, 2017 |
| Actual Study Completion Date : | June 5, 2017 |